• KARM
  • Contact us
  • E-Submission
ABOUT
ARTICLE TYPES
BROWSE ARTICLES
AUTHOR INFORMATION

Page Path

2
results for

"Hyeon Jun Oh"

Filter

Article category

Keywords

Publication year

Authors

"Hyeon Jun Oh"

Original Articles
Improvement of Peak Cough Flow After the Application of a Mechanical In-exsufflator in Patients With Neuromuscular Disease and Pneumonia: A Pilot Study
Ji Ho Jung, Hyeon Jun Oh, Jang Woo Lee, Mi Ri Suh, Jihyun Park, Won Ah Choi, Seong-Woong Kang
Ann Rehabil Med 2018;42(6):833-837.   Published online December 28, 2018
DOI: https://doi.org/10.5535/arm.2018.42.6.833
Objective
To investigate and demonstrate persistent increase of peak cough flow after mechanical in-exsufflator application, in patients with neuromuscular diseases and pneumonia.
Methods
A mechanical in-exsufflator was applied with patients in an upright or semi-upright sitting position (pressure setting, +40 and −40 cmH2O; in-exsufflation times, 2–3 and 1–2 seconds, respectively). Patients underwent five cycles, with 20–30 second intervals to prevent hyperventilation. Peak cough flow without and with assistive maneuvers, was evaluated before, and 15 and 45 minutes after mechanical in-exsufflator application.
Results
Peak cough flow was 92.6 L/min at baseline, and 100.4 and 100.7 L/min at 15 and 45 minutes after mechanical in-exsufflator application, respectively. Assisted peak cough flow at baseline, 15 minutes, and 45 minutes after mechanical in-exsufflator application was 170.7, 179.3, and 184.1 L/min, respectively. While peak cough flow and assisted peak cough flow increased significantly at 15 minutes after mechanical in-exsufflator application compared with baseline (p=0.030 and p=0.016), no statistical difference was observed between 15 and 45 minutes.
Conclusion
Increased peak cough flow after mechanical in-exsufflator application persists for at least 45 minutes.

Citations

Citations to this article as recorded by  
  • Physiological Effects of Mechanical Insufflation-Exsufflation in Patients With Neuromuscular Disease: A Scoping Review
    Lisa Edel, Tiina Andersen, Emma Shkurka
    Respiratory Care.2025;[Epub]     CrossRef
  • Pearls and pitfalls of respiratory testing in a patient with amyotrophic lateral sclerosis and COPD
    Stephen W. Littleton, Franco Laghi
    Breathe.2023; 19(2): 230043.     CrossRef
  • The use of cough peak flow in the assessment of respiratory function in clinical practice- A narrative literature review
    M. Brennan, M.J. McDonnell, N. Duignan, F. Gargoum, R.M. Rutherford
    Respiratory Medicine.2022; 193: 106740.     CrossRef
  • Comparison of two mechanical insufflation-exsufflation devices in patients with amyotrophic lateral sclerosis: a preliminary study
    Antonello NICOLINI, Paola PRATO, Laura BECCARELLI, Bruna GRECCHI, Giancarlo GARUTI, Paolo BANFI, Francesco D’ABROSCA
    Panminerva Medica.2022;[Epub]     CrossRef
  • Analysis of Pneumothorax in Noninvasive Ventilator Users With Duchenne Muscular Dystrophy
    Han Eol Cho, Justin Byun, Won Ah Choi, Myungsang Kim, Kyeong Yeol Kim, Seong-Woong Kang
    Chest.2021; 159(4): 1540.     CrossRef
  • 9,241 View
  • 180 Download
  • 6 Web of Science
  • 5 Crossref
Correlation of Serum Creatine Kinase Level With Pulmonary Function in Duchenne Muscular Dystrophy
Eun Young Kim, Jang Woo Lee, Mi Ri Suh, Won Ah Choi, Seong Woong Kang, Hyeon Jun Oh
Ann Rehabil Med 2017;41(2):306-312.   Published online April 27, 2017
DOI: https://doi.org/10.5535/arm.2017.41.2.306
Objective

To investigate the relationship between serum creatine kinase (CK) level and pulmonary function in Duchenne muscular dystrophy (DMD).

Methods

A total of 202 patients with DMD admitted to the Department of Rehabilitation Medicine, Gangnam Severance Hospital were enrolled from January 1, 1999 to March 31, 2015. Seventeen patients were excluded. Data collected from the 185 patients included age, height, weight, body mass index, pulmonary function tests including forced vital capacity (FVC), peak cough flow, maximal expiratory pressure (MEP), and maximal inspiratory pressure (MIP), and laboratory measurements (serum level of CK, CK-MB, troponin-T, and B-type natriuretic peptide). FVC, MEP, and MIP were expressed as percentages of predicted normal values.

Results

Serum CK activities were elevated above normal levels, even in the oldest DMD group. Serum CK level was strongly correlated with pulmonary functions of sitting FVC (p<0.001), supine FVC (p<0.001), MIP (p=0.004), and MEP (p<0.001).

Conclusion

Serum CK level is a reliable screening test even in patients with advanced DMD, and is a strong predictor of pulmonary functions.

Citations

Citations to this article as recorded by  
  • Cardiac and skeletal muscle delivery of biotherapeutics with a blood vessel epicardial substance-targeting peptide
    Biaobiao Wang, Jiahui Cao, Jingqiao Wu, Yiwen Zhao, Yao Zhang, Frank Abendroth, Caorui Lin, Li Zhong, Huanan Yu, Yiqi Seow, Meitong Ou, Olalla Vázquez, Lin Mei, HaiFang Yin, Gang Han
    Biomaterials.2026; 329: 123986.     CrossRef
  • Orthopaedic Management in Duchenne Muscular Dystrophy
    Uma Balachandran, Taylor Mustapich, Sheena C. Ranade
    Journal of the Pediatric Orthopaedic Society of North America.2025; 10: 100154.     CrossRef
  • Fighting for every beat: cardiac therapies in Duchenne muscular dystrophy
    Antoine Muchir
    Skeletal Muscle.2025;[Epub]     CrossRef
  • In Vivo Phage Display for the Identification of Muscle Homing Peptides to Improve the Delivery of Phosphorodiamidate Morpholino Oligomers for Duchenne Muscular Dystrophy Therapy
    Anne-Fleur E. Schneider, Christa L. Tanganyika-de Winter, Hailiang Mei, Silvana M.G. Jirka, Xuyu Tan, Emily G. Thompson, Kristin Ha, Anindita Mitra, Stephanie Garcia, Marleen Luimes, Ryan Oliver, Kathy Y. Morgan, Vincent Guerlavais, Annemieke Aartsma-Rus
    Nucleic Acid Therapeutics.2025; 35(5): 220.     CrossRef
  • Statistical Genetics of DMD Gene Mutations in a Kazakhstan Cohort: MLPA/NGS Variant Validation and Genotype–Phenotype Modelling
    Aizhan Moldakaryzova, Dias Dautov, Saken Khaidarov, Saniya Ossikbayeva, Dilyara Kaidarova
    Genes.2025; 17(1): 20.     CrossRef
  • N-terminal titin fragment: a non-invasive, pharmacodynamic biomarker for microdystrophin efficacy
    Jessica F. Boehler, Kristy J. Brown, Valeria Ricotti, Carl A. Morris
    Skeletal Muscle.2024;[Epub]     CrossRef
  • Personalized and muscle-specific OXPHOS measurement with integrated CrCEST MRI and proton MR spectroscopy
    Ryan R. Armbruster, Dushyant Kumar, Blake Benyard, Paul Jacobs, Aditi Khandavilli, Fang Liu, Ravi Prakash Reddy Nanga, Shana McCormack, Anne R. Cappola, Neil Wilson, Ravinder Reddy
    Nature Communications.2024;[Epub]     CrossRef
  • Synthetic datasets for open software development in rare disease research
    Ibraheem Al-Dhamari, Hammam Abu Attieh, Fabian Prasser
    Orphanet Journal of Rare Diseases.2024;[Epub]     CrossRef
  • Unveiling the Respiratory Muscle Strength in Duchenne Muscular Dystrophy: The Impact of Nutrition and Thoracic Deformities, Beyond Spirometry
    Mine Yuksel Kalyoncu, Yasemin Gokdemir, Cansu Yilmaz Yegit, Muruvvet Yanaz, Aynur Gulieva, Merve Selcuk, Şeyda Karabulut, Neval Metin Çakar, Pinar Ergenekon, Ela Erdem Eralp, Gülten Öztürk, Olcay Unver, Dilsad Turkdogan, Yavuz Sahbat, Ahmet Hamdi Akgülle,
    Children.2024; 11(8): 994.     CrossRef
  • Duchenne Muscular Dystrophy in Two Half-Brothers Due to Inherited 306 Kb Inverted Insertion of 10p15.1 into Intron 44 of the Dp427m Transcript of the DMD Gene
    Wayne M. Jepsen, Andrew Fazenbaker, Keri Ramsey, Anna Bonfitto, Marcus Naymik, Bryce Turner, Jennifer Sloan, Nishant Tiwari, Saunder M. Bernes, Derek E. Neilson, Meredith Sanchez-Castillo, Matt J. Huentelman, Vinodh Narayanan
    International Journal of Molecular Sciences.2024; 25(22): 11922.     CrossRef
  • Chronic granulomatous disease associated with Duchenne muscular dystrophy caused by Xp21.1 contiguous gene deletion syndrome: Case report and literature review
    Shaohua Bi, Liying Dai, Liangliang Jiang, Lili Wang, Mia Teng, Guanghui Liu, Ru-Jeng Teng
    Frontiers in Genetics.2023;[Epub]     CrossRef
  • Urine titin as a novel biomarker for Duchenne muscular dystrophy
    Misawa Niki Ishii, Masato Nakashima, Hidenori Kamiguchi, Neta Zach, Ryosuke Kuboki, Rina Baba, Takeshi Hirakawa, Kazunori Suzuki, Maria Quinton
    Neuromuscular Disorders.2023; 33(4): 302.     CrossRef
  • Creatine Kinase Is Decreased in Childhood Asthma
    Stefano Guerra, Julie G. Ledford, Erik Melén, Iris Lavi, Anne-Elie Carsin, Debra A. Stern, Jing Zhai, Marta Vidal, Mariona Bustamante, Kenneth J. Addison, Renata G. Vallecillo, Dean Billheimer, Gerard H. Koppelman, Judith Garcia-Aymerich, Nathanaël Lemonn
    American Journal of Respiratory and Critical Care Medicine.2023; 207(5): 544.     CrossRef
  • Advances in Dystrophinopathy Diagnosis and Therapy
    Fawzy A. Saad, Gabriele Siciliano, Corrado Angelini
    Biomolecules.2023; 13(9): 1319.     CrossRef
  • MOTS‐c promotes phosphorodiamidate morpholino oligomer uptake and efficacy in dystrophic mice
    Ning Ran, Caorui Lin, Ling Leng, Gang Han, Mengyuan Geng, Yingjie Wu, Scott Bittner, Hong M Moulton, HaiFang Yin
    EMBO Molecular Medicine.2021;[Epub]     CrossRef
  • RESPIRATORY MUSCLE IMPAIRMENT EVALUATED WITH MEP/MIP RATIO IN CHILDREN AND ADOLESCENTS WITH CHRONIC RESPIRATORY DISEASE
    Iván Rodríguez-Núñez, Gerardo Torres, Soledad Luarte-Martinez, Carlos Manterola, Daniel Zenteno
    Revista Paulista de Pediatria.2021;[Epub]     CrossRef
  • A Blood Biomarker for Duchenne Muscular Dystrophy Shows That Oxidation State of Albumin Correlates with Protein Oxidation and Damage in Mdx Muscle
    Basma A. Al-Mshhdani, Miranda D. Grounds, Peter G. Arthur, Jessica R. Terrill
    Antioxidants.2021; 10(8): 1241.     CrossRef
  • High‑dose intravenous immunoglobulins as a therapeutic option in critical illness polyneuropathy accompanying SARS‑CoV‑2 infection: A case‑based review of the literature (Review)
    Adina Stoian, Zoltan Bajko, Smaranda Maier, Roxana Cioflinc, Bianca Grigorescu, Anca Moțățăianu, Laura Bărcuțean, Rodica Balașa, Mircea Stoian
    Experimental and Therapeutic Medicine.2021;[Epub]     CrossRef
  • Intensive Care Unit-Acquired Weakness: Not Just Another Muscle Atrophying Condition
    Heta Lad, Tyler M. Saumur, Margaret S. Herridge, Claudia C. dos Santos, Sunita Mathur, Jane Batt, Penney M. Gilbert
    International Journal of Molecular Sciences.2020; 21(21): 7840.     CrossRef
  • Proteomic serum biomarkers for neuromuscular diseases
    Sandra Murphy, Margit Zweyer, Rustam R. Mundegar, Dieter Swandulla, Kay Ohlendieck
    Expert Review of Proteomics.2018; 15(3): 277.     CrossRef
  • Necroptosis mediates myofibre death in dystrophin-deficient mice
    Jennifer E. Morgan, Alexandre Prola, Virginie Mariot, Veronica Pini, Jinhong Meng, Christophe Hourde, Julie Dumonceaux, Francesco Conti, Frederic Relaix, Francois-Jerôme Authier, Laurent Tiret, Francesco Muntoni, Maximilien Bencze
    Nature Communications.2018;[Epub]     CrossRef
  • LIMB GIRDLE MUSCULAR DYSTROPHY IN EARLY CHILDHOOD- CLINICAL HETEROGENEITY AND CLUE TO EARLY DIAGNOSIS
    Beena Vasanthy, Vijayan Chandrathil Parameswaran Nair
    Journal of Evidence Based Medicine and Healthcare.2018; 5(41): 2907.     CrossRef
  • Immunobiology of Inherited Muscular Dystrophies
    James G. Tidball, Steven S. Welc, Michelle Wehling‐Henricks
    Comprehensive Physiology.2018; 8(4): 1313.     CrossRef
  • Comparative Analysis of Serum Proteins from Patients with Severe and Mild EV‐A71‐induced HFMD using iTRAQ‐Coupled LC‐MS/MS Screening
    Peihu Fan, Wei Chen, Pin Yu, Linlin Bao, Lili Xu, Chuan Qin
    PROTEOMICS – Clinical Applications.2017;[Epub]     CrossRef
  • 18,135 View
  • 117 Download
  • 24 Web of Science
  • 24 Crossref
TOP